167 related articles for article (PubMed ID: 37378622)
21. In vivo regulation of plasma free fatty acids in insulin resistance.
Mook S; Halkes Cj Cj; Bilecen S; Cabezas MC
Metabolism; 2004 Sep; 53(9):1197-201. PubMed ID: 15334384
[TBL] [Abstract][Full Text] [Related]
22. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action.
Howard BV; Klimes I; Vasquez B; Brady D; Nagulesparan M; Unger RH
J Clin Endocrinol Metab; 1984 Mar; 58(3):544-8. PubMed ID: 6363441
[TBL] [Abstract][Full Text] [Related]
23. Free fatty acids-the link between obesity and insulin resistance.
Boden G
Endocr Pract; 2001; 7(1):44-51. PubMed ID: 11250769
[TBL] [Abstract][Full Text] [Related]
24. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance.
Moran A; Basu R; Milla C; Jensen MD
Metabolism; 2004 Nov; 53(11):1467-72. PubMed ID: 15536603
[TBL] [Abstract][Full Text] [Related]
25. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
[TBL] [Abstract][Full Text] [Related]
26. Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adults.
Malin SK; Kashyap SR; Hammel J; Miyazaki Y; DeFronzo RA; Kirwan JP
Diabetes Care; 2014 Nov; 37(11):2940-6. PubMed ID: 25139885
[TBL] [Abstract][Full Text] [Related]
27. Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes.
Schembri Wismayer D; Laurenti MC; Song Y; Egan AM; Welch AA; Bailey KR; Cobelli C; Dalla Man C; Jensen MD; Vella A
Am J Physiol Endocrinol Metab; 2023 Aug; 325(2):E119-E131. PubMed ID: 37285600
[TBL] [Abstract][Full Text] [Related]
28. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
Sumner AE; Kushner H; Sherif KD; Tulenko TN; Falkner B; Marsh JB
Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906
[TBL] [Abstract][Full Text] [Related]
29. Regional postprandial fatty acid metabolism in different obesity phenotypes.
Guo Z; Hensrud DD; Johnson CM; Jensen MD
Diabetes; 1999 Aug; 48(8):1586-92. PubMed ID: 10426377
[TBL] [Abstract][Full Text] [Related]
30. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study.
Gastaldelli A; Gaggini M; DeFronzo RA
Diabetes; 2017 Apr; 66(4):815-822. PubMed ID: 28052966
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
Capaldo B; Napoli R; Di Marino L; Picardi A; Riccardi G; Sacca L
J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
[TBL] [Abstract][Full Text] [Related]
32. Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes.
Salgin B; Ong KK; Thankamony A; Emmett P; Wareham NJ; Dunger DB
J Clin Endocrinol Metab; 2012 Sep; 97(9):3302-9. PubMed ID: 22740706
[TBL] [Abstract][Full Text] [Related]
33. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
34. Fat metabolism in human obesity.
Campbell PJ; Carlson MG; Nurjhan N
Am J Physiol; 1994 Apr; 266(4 Pt 1):E600-5. PubMed ID: 8178981
[TBL] [Abstract][Full Text] [Related]
35. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
36. NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test.
Boston RC; Moate PJ
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R395-403. PubMed ID: 18565832
[TBL] [Abstract][Full Text] [Related]
37. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
[TBL] [Abstract][Full Text] [Related]
38. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
[TBL] [Abstract][Full Text] [Related]
39. Modeling glucose and free fatty acid kinetics in glucose and meal tolerance test.
Li Y; Chow CC; Courville AB; Sumner AE; Periwal V
Theor Biol Med Model; 2016 Mar; 13():8. PubMed ID: 26934990
[TBL] [Abstract][Full Text] [Related]
40. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
